logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
International Journal of Neuropsychopharmacology cover

International Journal of Neuropsychopharmacology

IF3.7
Papers1239
Citations6987
Journal Papers 1203
Publication Date
delete
PDE4A Knockdown Rescues Alcohol-Induced Cognitive Impairment and Synaptic Dysfunction via the cAMP/PKA/CREB Pathway
deleteInternational Journal of Neuropsychopharmacology
IF3.7
delete2026-07-11
delete0
deleteOAAI
deleteHuan Tu, MS; Rongzhen Sun, MR; Shengyao Ma, MR; Chunxu Li, MR; Mingti Lv, MS; Mei Han, PhD; Han-Ting Zhang, PhD
deleteShare
deleteSave
In Memoriam: Professor Shigeto Yamawaki (15 January 1954 – 8 June 2026) — A Visionary Leader Connecting Japan, Asia, and the World
deleteInternational Journal of Neuropsychopharmacology
IF3.7
delete2026-07-07
delete0
deleteOAAI
deleteKazutaka Ikeda; Gabriella Gobbi; Joseph Zohar; Gregers Wegener; Pierre Blier; Siegfried Kasper; John H Krystal; Anthony Phillips; Hans-Jürgen Möller; Toshikazu Saito; Hiroyuki Uchida; Atsumi Nitta; Go Okada
deleteShare
deleteSave
Ketamine effects on EEG and their links to therapy differ across treatment-resistant major depression, post-traumatic stress disorder, and obsessive-compulsive disorder
deleteInternational Journal of Neuropsychopharmacology
IF3.7
delete2026-07-06
delete0
deleteOAAI
deleteShabah M Shadli; Neda Nasrollahi; Calvin K Young; Gabrielle S R Schuck; Meadow G Whatson; Tame Kawe; Shona Neehoff; Ben Beaglehole; Paul Glue; Neil McNaughton
deleteShare
deleteSave
Genetic overlap between treatment-resistant schizophrenia and smoking initiation
deleteInternational Journal of Neuropsychopharmacology
IF3.7
delete2026-06-28
delete0
deleteOAAI
deleteElise Koch, PhD; Nadine Parker, PhD; Helin H Mohammad, MSc; Hasan Ç Lenk, MD, PhD; Lars A R Ystaas, MD; Piotr Jaholkowski, MD, PhD; Alexey A Shadrin, PhD; Oleksandr Frei, PhD; Anders M Dale, PhD; Srdjan Djurovic, PhD; Espen Molden, PhD; Kevin S O’Connell, PhD; Ole A Andreassen, MD, PhD
deleteShare
deleteSave
External Validation as the Critical Step for Predictive Biomarkers
deleteInternational Journal of Neuropsychopharmacology
IF3.7
delete2026-06-25
delete0
deleteOAAI
deletePál Czobor, PhD; Brigitta Kakuszi, PhD; Máté Fullajtár, MD; István Bitter, MD, PhD
deleteShare
deleteSave
Viloxazine occupies the 5-HT2C receptor in the macaca fascicularis brain in vivo: A [11C]CIMBI-36 positron emission tomography study
deleteInternational Journal of Neuropsychopharmacology
IF3.7
delete2026-06-23
delete0
deleteOAAI
deleteJennie Garcia-Olivares, PhD; Brittney Yegla, PhD; Khanum Ridler, PhD; Gaia Rizzo, PhD; Zhen Fan, PhD; Amy Llopis Amenta, BS; Anton Forsberg Moren; Christer Halldin; Vladimir Stepanov; Jennifer Koch, PhD; Chungping Yu, PhD; Jonathan Rubin, MD; Vladimir Maletic, MD; Eugenii A Rabiner, MBBCh; null
deleteShare
deleteSave
Divergent effects of interleukin-6 and ghrelin on remission and relapse in depression treatment
deleteInternational Journal of Neuropsychopharmacology
IF3.7
delete2026-06-22
delete0
deleteOAAI
deleteJae-Min Kim, MD, PhD; Hee-Ju Kang, MD, PhD; Ju-Wan Kim, MD, MSc; Min Jhon, MD, MSc; Ju-Yeon Lee, MD, PhD; Sung-Wan Kim, MD, PhD; Il-Seon Shin, MD, PhD; null
deleteShare
deleteSave
Secondary Restless Legs Syndrome during Psychopharmacological Treatment: Real-World Evidence from a Multinational Pharmacovigilance Program
deleteInternational Journal of Neuropsychopharmacology
IF3.7
delete2026-06-07
delete0
deleteOAAI
deleteGernot Fugger; Ulrich Rabl; Lucie Bartova; Valentin Popper; Victoria Watzal; Dominik Ivkic; Jakob Donath; Constance Busvine; Waldemar Greil; Sermin Toto; Renate Grohmann; Richard Frey; Anastasios Konstantinidis; Andreas Erfurth; Siegfried Kasper; null
deleteShare
deleteSave
Recent Cannabis Exposure and Acute Nicotine Effects: Insights from Randomized, Double-Blind, Placebo-Controlled Intravenous Nicotine Studies
deleteInternational Journal of Neuropsychopharmacology
IF3.7
delete2026-05-26
delete0
deleteOAAI
deleteGabriel P A Costa, M D; R Ross MacLean, Ph.D; Mehmet Sofuoglu, M D, Ph.D; Joao P De Aquino, M D; null
deleteShare
deleteSave
Inhibition of FKBP51 alleviates depressive-like behaviors via AKT/mTOR-Dependent Autophagy and Synaptic Plasticity
deleteInternational Journal of Neuropsychopharmacology
IF3.7
delete2026-05-22
delete0
deleteOAAI
deleteChen Li, PhD; Junjie Huang, PhD; Hailong Ge, PhD; Lujia Si, PhD; Lan Wu, MD; Yinping Xie, PhD; Ling Xiao, PhD; Gaohua Wang, PhD; null
deleteShare
deleteSave
Negative allosteric modulator of the metabotropic glutamate receptor 7 (mGlu7) ADX71743 increases wakefulness, reduces sleep and alters stress-induced changes in the brain neurotransmitter levels
deleteInternational Journal of Neuropsychopharmacology
IF3.7
delete2026-05-11
delete0
deleteOAAI
deleteMikhail Kalinichev; John A Gruner; Gunnar Flik; Mariette Heins; Hasnaa Haddouk; Isabelle Royer-Urios; Simon T Bate; Sonia Poli; Robert Lütjens; null
deleteShare
deleteSave
Life Engagement Improvements with Cariprazine in Schizophrenia: A Post-Hoc Analysis of PANSS Data from Short-Term Studies
deleteInternational Journal of Neuropsychopharmacology
IF3.7
delete2026-05-08
delete0
deleteOAAI
deleteRéka Csehi, PhD; Péter Szabó, PhD; Zsófia Borbála Dombi, MSc; Thomas Brevig, MD, PhD; Balázs Szatmári, MD, PhD; Ágota Barabássy, MD, PhD
deleteShare
deleteSave
Late-onset major depression and subthreshold depressive symptoms as early clinical correlates of brain small vessel disease
deleteInternational Journal of Neuropsychopharmacology
IF3.7
delete2026-05-08
delete0
deleteOAAI
deleteCalypso Α Mitkani; Thomas J Tegos; Vasilios K Kimiskidis; Stavroula Koukou; Konstantinos N Fountoulakis
deleteShare
deleteSave
Heterogeneity in adverse events associated with lumateperone: a study on potential subgroup-specific differences
deleteInternational Journal of Neuropsychopharmacology
IF3.7
delete2026-05-08
delete0
deleteOAAI
deleteCheng Jiang; Luhan Tang; Mingqian Li; Guoqin Xia
deleteShare
deleteSave
The introduction of measurement-based care for patients with schizophrenia may improve psychiatric symptoms and guideline adherence rate
deleteInternational Journal of Neuropsychopharmacology
IF3.7
delete2026-05-08
delete0
deleteOAAI
deleteKeisuke Mori, MD, PhD; Junya Matsumoto, MD, PhD; Satsuki Ito, PhD; Kentaro Fukumoto, MD, PhD; Ken Inada, MD, PhD; Fumitoshi Kodaka, MD, PhD; Harumasa Takano, MD, PhD; Shinsuke Kito, MD, PhD; Ryota Hashimoto, MD, PhD
deleteShare
deleteSave
Increase of the AMPA-evoked response of pyramidal neurons in the rat medial prefrontal cortex following acute administration of ketamine and S-ketamine, but not R-ketamine
deleteInternational Journal of Neuropsychopharmacology
IF3.7
delete2026-05-07
delete0
deleteOAAI
deleteMostafa El Mansari; Naomichi Okamoto; Pierre Blier
deleteShare
deleteSave
Global Perspectives on CNS Drug Innovation: Achievements, Barriers, and Priorities for the Next Decade
deleteInternational Journal of Neuropsychopharmacology
IF3.7
delete2026-05-07
delete0
deleteOAAI
deleteHiroyuki Uchida, MD, PhD; Gabriella Gobbi, MD, PhD; Joseph Zohar, MD; Allan H Young, MB, ChB, PhD; Dan Rujescu, MD, PhD; Ming-Chyi Huang, MD, PhD; Suresh Sundram, MBBS, PhD; Lukoye Atwoli, MD, PhD; Jana Vukovic, PhD; Kazutaka Ikeda, PhD
deleteShare
deleteSave
Structural and functional neuroimaging correlates of suicidal ideation in treatment-resistant major depressive disorder
deleteInternational Journal of Neuropsychopharmacology
IF3.7
delete2026-05-01
delete0
PREAI
deleteBurhunduli, Patricia; Vandeloo, Katie L.; Fang, Zhuo; Blier, Pierre; Phillips, Jennifer L.
deleteShare
deleteSave
Distinct Therapeutic Profiles of Ketamine in Treatment-Resistant Depression: An Exploratory Analysis
deleteInternational Journal of Neuropsychopharmacology
IF3.7
delete2026-04-30
delete0
deleteOAAI
deleteKuan-I Liu, MD; Wei-Chen Lin, MD, PhD; Cheng-Ta Li, MD, PhD; Ya-Mei Bai, MD, PhD; Tung-Ping Su, MD; Mu-Hong Chen, MD, PhD
deleteShare
deleteSave
Three-week effect of amisulpride, aripiprazole, and olanzapine on gene expression in peripheral blood in individuals with schizophrenia spectrum disorders
deleteInternational Journal of Neuropsychopharmacology
IF3.7
delete2026-04-25
delete0
deleteOAAI
deleteAnja Torsvik; Andrea Trentani; Tomasz K Stokowy; Silje Skrede; Inge Joa; Solveig M Klæbo Reitan; Maria Rettenbacher; Rune A Kroken; Erik Johnsen; Vidar M Steen
deleteShare
deleteSave